Oncology Strategy & Development Lead
About Ataraxis AI Ataraxis is an AI precision medicine company working at the intersection of multi-modal artificial intelligence and oncology. We develop and deploy AI-native tools to assist physicians in selecting the most optimal treatments for their patients. Our mission is to change how cancer is treated and impact at least 50% of new cancer cases by 2030. We have already launched our first products, including the Ataraxis™ Breast platform for breast cancer, and help cancer patients get the most appropriate treatment every day. We work with the best academic institutions in the United States as well as small community clinics to deliver better care with frontier technology. At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of healthcare-focused AI research and deployment. As a frontier AI lab, we bring together leading AI researchers, medical doctors, and industry veterans. Our advisors include AI pioneers such as Yann LeCun and distinguished oncologists from top cancer research institutions, all united by the mission to redefine precision medicine. Ataraxis has raised $24 million in funding, including a $20.4 million Series A in early 2025 led by top venture capital funds such as AIX Ventures (Hugging Face, Perplexity), Thiel Capital, Founders Fund (OpenAI, SpaceX, Palantir, Oscar Health), and Obvious Ventures (Recursion). We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.
Responsibilities
You will lead expansion of Ataraxis’s offerings to one of the next cancer types beyond breast cancer. Ataraxis has developed a pan-cancer AI platform that has been internally validated to perform well across various tumor types. This role will work on creating the right environment for the commercial launch in the next cancer type(s). In that process, you will: Source real-world datasets, clinical trial datasets, and biobank resources to support AI model development and evaluation Develop and manage a network of relationships with key opinion leaders, clinical advisors, early adopters, and research collaborators to validate hypotheses, gather insights, and identify potential customers and partners Develop internal knowledge (memos, draft collateral material) in preparation for medical affairs/sales teams in the future Work directly with the CEO to execute on this launch in record speed Partner with engineering and research teams to inform clinical-grade model development Qualifications 2+ years of industry experience in biotech, pharma, diagnostics, or healthcare strategy, management consulting, or finance Preferred: MD, PhD, PharmD, NP, or Master's in MD, PhD, PharmD, NP, or a Master’s degree in cancer biology, molecular biology, cell biology, biomedical sciences, pharmacology, pharmaceutical sciences, or a related life sciences field Ability to quickly and independently process and learn new and complex scientific and medical topics Strong soft skills and being able to speak to various audiences, from medical key opinion leaders to software engineers. Optional but preferred: experience presenting scientific content to audiences Preferred: Experience writing academic/scientific content (e.g., peer-reviewed manuscripts, academic grant applications) Bias for action Ability to understand the big picture behind research and development and how it needs to translate to customers’ experience and product quality Total compensation includes a base salary of $120,000–$170,000, equity, and a full benefits package, structured to reflect the strategic impact and seniority of this role. Apply To This Job